Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery
An Intravascular Ultrasound Study
Anna Sonia Petronio, MD*,
Marco De Carlo, MD, PhD,
Giulia Branchitta, MD,
Barbara Papini, RT,
Nicola Ciabatti, MD, PhD,
Roberto Gistri, MD,
Bernardo Cortese, MD,
Gherardo Gherarducci, MD and
Antonio Barsotti, MD
Cardiology Unit, Cardiothoracic Department, University of Pisa, Pisa, Italy
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Comparison of Changes in Vessel, Plaque, and Lumen Areas Between SES and PES
Averaged changes (follow-up minus post-procedure) in vessel, plaque, and lumen areas in the stented segment. Abbreviations as in Figure 1.
|
|
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Correlation of Neointimal Hyperplasia-Free Stent Length and Neointimal Hyperplasia Area Percent
Correlation of percent neointimal hyperplasia-free stent length and percent neointimal hyperplasia area in paclitaxel (solid circles = solid regression line) and sirolimus-eluting stents (open diamonds = dashed regression line).
|
|
|
